GlassScriptPhysician profile
Donald Stewart
NPI 1932212487
$1,649.80
in general payments reported to CMS, 2019-2025
12 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2021: $114 · 2022: $91.49 · 2023: $142 · 2024: $45.06 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280 · Travel and Lodging: $27.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.59 |
| Travel and Lodging | $27.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $742.79 | 2019-2021 | |
| Boston Scientific Corporation | $354.33 | 2019-2025 | Bulkamid |
| Astellas Pharma US INC | $234.31 | 2019 | |
| Axonics, INC. | $78.22 | 2023 | Axonics |
| Urogen Pharma, INC. | $63.58 | 2023 | Jelmyto |
| Janssen Biotech, INC. | $50.43 | 2019 | |
| Pfizer INC. | $34.00 | 2019 | |
| Treace Medical Concepts, INC. | $27.92 | 2024 | |
| Metuchen Pharmaceuticals | $22.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.43 | 2019 | |
| Travere Therapeutics, INC. | $13.11 | 2019 | |
| Allergan, INC. | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.